对理想流感疫苗的探索。
The search for the ideal influenza vaccine.
作者信息
Davenport F M
出版信息
Postgrad Med J. 1979 Feb;55(640):78-86. doi: 10.1136/pgmj.55.640.78.
Abstract
The history of the development of influenza virus vaccine is traced from its origin with experimental studies of influenza virus in ferrets and mice and the first trials in man. Knowledge of the basis of immunity to the viruses in experimental animals and in man has grown steadily over the years and has been essential to successful immunization. Virus variation affecting the surface antigens of the virus is seen as the principal obstacle to the application of vaccines in man. So significant are the changes occurring during antigenic drift that former concepts of a polyvalent vaccine cannot provide a solution of the problem of the composition of vaccines. Disrupted virus vaccines appear to provide the answer to the prevention of vaccine reactions.
摘要
流感病毒疫苗的发展历程可追溯至其起源，当时在雪貂和小鼠身上对流感病毒进行了实验研究，并首次在人体上进行了试验。多年来，人们对实验动物和人体中针对这些病毒的免疫基础的认识不断深入，这对成功免疫至关重要。影响病毒表面抗原的病毒变异被视为疫苗在人体应用的主要障碍。抗原漂移期间发生的变化非常显著，以至于以前关于多价疫苗的概念无法解决疫苗成分的问题。裂解病毒疫苗似乎为预防疫苗反应提供了答案。
相似文献
1
The search for the ideal influenza vaccine.对理想流感疫苗的探索。
Postgrad Med J. 1979 Feb;55(640):78-86. doi: 10.1136/pgmj.55.640.78.
2
Influenza: the vaccines.
Hosp Pract. 1976 Nov;11(11):65-70. doi: 10.1080/21548331.1976.11707029.
3
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.神经氨酸酶抑制抗体滴度与对同一神经氨酸酶亚型的异源流感病毒株的保护作用相关。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.01006-18. Print 2018 Sep 1.
4
Control of influenza and poliomyelitis with killed virus vaccines.使用灭活病毒疫苗控制流感和脊髓灰质炎
Science. 1977 Mar 4;195(4281):834-47. doi: 10.1126/science.320661.
5
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus.当前甲型流感病毒的抗原变异：香港病毒抗原“漂移”高频发生的证据。
Bull World Health Organ. 1974;51(1):1-11.
6
Influenza Virus: Dealing with a Drifting and Shifting Pathogen.流感病毒：应对一种不断漂移和变异的病原体。
Viral Immunol. 2018 Mar;31(2):174-183. doi: 10.1089/vim.2017.0141. Epub 2018 Jan 26.
7
Challenges of Making Effective Influenza Vaccines.制作有效流感疫苗的挑战。
Annu Rev Virol. 2020 Sep 29;7(1):495-512. doi: 10.1146/annurev-virology-010320-044746. Epub 2020 May 11.
8
Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.减毒活流感疫苗对儿童 B 型流感病毒的效力与谱系和抗原相似性有关。
Vaccine. 2010 Feb 25;28(9):2149-56. doi: 10.1016/j.vaccine.2009.11.068. Epub 2009 Dec 8.
9
Changing perspective on immunization against influenza.对流感免疫的观念转变。
Vaccine. 2007 Apr 20;25(16):3062-5. doi: 10.1016/j.vaccine.2007.01.030. Epub 2007 Jan 19.
10
Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.通过计算优化的广泛反应性血凝素可引发针对一组H3N2流感病毒共同流行变体的血凝抑制抗体。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01581-17. Print 2017 Dec 15.
引用本文的文献
1
From influenza to COVID-19 vaccinations: Counselling anxious parents about deaths following influenza immunizations in Korea.从流感疫苗接种到新冠疫苗接种：为韩国焦虑的父母提供关于流感疫苗接种后死亡事件的咨询服务
Pediatr Pulmonol. 2021 Jun;56(6):1779-1781. doi: 10.1002/ppul.25260. Epub 2021 Mar 25.
2
Cardiovascular implications of COVID-19 versus influenza infection: a review.COVID-19 与流感感染的心血管影响：综述。
BMC Med. 2020 Dec 18;18(1):403. doi: 10.1186/s12916-020-01816-2.
3
History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines.通过接种疫苗控制流感的历史与演变：从首款单价疫苗到通用疫苗
J Prev Med Hyg. 2016 Sep;57(3):E115-E120.
4
Changing perceptions: of pandemic influenza and public health responses.改变观念：大流行性流感和公共卫生应对措施。
Am J Public Health. 2012 Jan;102(1):90-8. doi: 10.2105/AJPH.2011.300330. Epub 2011 Nov 28.
5
Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses.由重组流感病毒制备的灭活疫苗在仓鼠体内的抗原性。
J Hyg (Lond). 1981 Dec;87(3):453-64. doi: 10.1017/s0022172400069709.
本文引用的文献
1
Influenza: Four Years' Progress.流感：四年进展
Br Med J. 1937 Sep 11;2(4001):513-5. doi: 10.1136/bmj.2.4001.513.
2
Isolation of Influenza Virus: The Manchester Epidemic.流感病毒的分离：曼彻斯特疫情
Br Med J. 1937 Mar 27;1(3977):655-7. doi: 10.1136/bmj.1.3977.655.
3
QUANTITATIVE ASPECTS OF THE RED BLOOD CELL AGGLUTINATION TEST FOR INFLUENZA VIRUS.流感病毒红细胞凝集试验的定量方面。
J Exp Med. 1944 Feb 1;79(2):185-95. doi: 10.1084/jem.79.2.185.
4
ANTIBODY RESPONSE OF HUMAN BEINGS FOLLOWING VACCINATION WITH INFLUENZA VIRUSES.人类接种流感病毒后的抗体反应。
J Exp Med. 1942 May 1;75(5):495-511. doi: 10.1084/jem.75.5.495.
5
THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION.红细胞凝集法测定流感病毒及抗体。
J Exp Med. 1942 Jan 1;75(1):49-64. doi: 10.1084/jem.75.1.49.
6
STUDIES ON THE NASAL HISTOLOGY OF EPIDEMIC INFLUENZA VIRUS INFECTION IN THE FERRET : III. HISTOLOGICAL AND SEROLOGICAL OBSERVATIONS ON FERRETS RECEIVING REPEATED INOCULATIONS OF EPIDEMIC INFUENZA VIRUS.有关流感病毒在雪貂中感染的鼻腔组织学研究：III. 重复接种流感病毒后雪貂的组织学和血清学观察。
J Exp Med. 1938 Oct 31;68(6):813-30. doi: 10.1084/jem.68.6.813.
7
STUDIES ON THE NASAL HISTOLOGY OF EPIDEMIC INFLUENZA VIRUS INFECTION IN THE FERRET : II. THE RESISTANCE OF REGENERATING RESPIRATORY EPITHELIUM TO REINFECTION AND TO PHYSICOCHEMICAL INJURY.有关在雪貂中流行流感病毒感染的鼻组织学研究：Ⅱ. 再生呼吸道上皮对再感染和理化损伤的抵抗力。
J Exp Med. 1938 Oct 31;68(6):803-12. doi: 10.1084/jem.68.6.803.
8
STUDIES ON THE NASAL HISTOLOGY OF EPIDEMIC INFLUENZA VIRUS INFECTION IN THE FERRET : I. THE DEVELOPMENT AND REPAIR OF THE NASAL LESION.有关在雪貂中流行感冒病毒感染的鼻腔组织学研究：I. 鼻腔病变的发展与修复。
J Exp Med. 1938 Oct 31;68(6):789-802. doi: 10.1084/jem.68.6.789.
9
THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION.经体外培养改良的黄热病病毒用于人体免疫。
J Exp Med. 1937 May 31;65(6):787-800. doi: 10.1084/jem.65.6.787.
10
THE ANTIBODY RESPONSE OF HUMAN SUBJECTS VACCINATED WITH THE VIRUS OF HUMAN INFLUENZA.人体接种流感病毒后的抗体反应。
J Exp Med. 1937 Jan 31;65(2):251-9. doi: 10.1084/jem.65.2.251.
Zotero 插件